Koers Tiziana Life London S.E.
Aandelen
TILS
GB00BKWNZY55
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 56,17 mln. 52,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -15 mln. -13,93 mln. | Nettowinst (verlies) 2023 | -17 mln. -15,79 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 17,76 mln. 16,49 mln. | Nettoliquiditeiten 2023 | 936K 869K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-3,95
x | K/w-verhouding 2023 |
-3,29
x | Werknemers | 9 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 32,56% |
Recentste transcriptie over Tiziana Life
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01-07-20 |
Willy Simon
BRD | Director/Board Member | 72 | 01-11-15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |